Metra Biosystems enters talks with unnamed buyer:
This article was originally published in Clinica
Executive Summary
Diagnostic company Metra Biosystems is negotiating with an unnamed buyer. The companies have entered into an initial 30-day period of exclusivity to form a definitive agreement. Mountain View, California-based Metra develops products for the detection and management of metabolic bone diseases and disorders. Late last year, Metra announced plans to merge with fellow point-of-care diagnostics company Spectral Diagnostics, only to call the deal off within two months (see Clinica No 845, p 8).